ABSTRACT-To determine the source of angiotensinogen excreted in urine, urine angiotensinogen was measured in male and female rats during growth. Angiotensinogen in 24-hr urine, measured by direct radioimmunoassay with antibody against rat angiotensinogen, increased fourfold in males between the ages of 5 and 7 weeks, whereas no significant changes were observed in females or castrated males. Plasma levels of angiotensinogen, in contrast, showed no significant differences between these groups at any age. Castra tion of adult males caused a significant reduction of urinary angiotensinogen after 4 weeks. Consecutive s.c. administration of 17a-methyltestosterone for 3 weeks in castrated males resulted in a threefold increase in the urinary excretion of angiotensinogen, as well as a twofold increase in the renal expression of angioten sinogen messenger RNA (mRNA). Renal levels of angiotensinogen mRNA in intact adult males were about threefold higher than those in females and castrated males, whereas there were no significant differences in hepatic angiotensinogen mRNA between these animals. These results suggest that the sexual differences in the urinary excretion of angiotensinogen are primarily due to the androgen-dependent dimorphic expression of angiotensinogen mRNA in the kidney; thus, levels of angiotensinogen in urine might reflect intrarenal production.
Angiotensinogen, a plasma protein synthesized mainly by the liver, is cleaved by renin to release a decapeptide, angiotensin I. Subsequently, angiotensin I is further hydrolyzed by converting-enzyme to produce the octapep tide, angiotensin II, a biologically active molecule that plays an important role in the regulation of blood pres sure and electrolyte balance.
In a previous study (1), we found a protein in rat urine that cross-reacted with antibody against rat angiotensin ogen and released angiotensin I in the presence of renin. Since the molecular size of the immunoreactive material could not be distinguished from plasma angiotensinogen on sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis, we concluded that angiotensinogen was present in rat urine, although the source was not deter mined (1). Two possible sources for urine angiotensin ogen can be considered: (i) Angiotensinogen in the circu lation, which may appear in glomerular filtrates, is like other plasma proteins, normally detected in urine. In fact, the molecular size and the isoelectric point of rat angiotensinogen are close to those of albumin, a plasma protein that normally appears in urine. (ii) All components of the renin-angiotensin system, i.e., renin, angiotensin I, angiotensin II, converting-enzyme and angiotensinogen have been detected biochemically in renal tissue (2) . Using in situ hybridization technique, Ingelfinger et al. (3) have demonstrated that angiotensinogen messenger RNA (mRNA) in rat kidney is localized predominantly in the proximal convoluted tubule, with lesser amounts in distal tubular segments and glomerular tufts, suggesting that angiotensinogen might be secreted from the proximal tubule. It has been shown by Ellison et al. (4) that renal an giotensinogen mRNA levels increased in the male but not in the female rat during puberty. From their observations that castration lowered angiotensinogen mRNA levels in the male kidney and that testosterone replacement therapy restored the levels in the castrated male rat, these investigators suggested that the sexual dimorphic expres sion of renal angiotensinogen mRNA in the rat was andro gen dependent (4) . This evidence suggests that if urine angiotensinogen is derived from the proximal tubule and other intrarenal tissues, then an androgen-dependent sex ual difference might also be observed in angiotensinogen levels in the urine. In our present study, we investigated the urinary excretion of angiotensinogen in male and female rats during growth. Our results indicate that there is an androgen-dependent sexual difference in urine an giotensinogen levels, and this difference is closely correlat ed with angiotensinogen mRNA expression in the kidney, but not in the liver, suggesting that the major source of urine angiotensinogen is the renal tissue.
MATERIALS AND METHODS

Animals
Sprague-Dawley rats, obtained from Japan SLC (Hamamatsu), were housed in regular cages in a room maintained at 221C, and they were fed a normal diet and tap water ad libitum.
Collection of urine and plasma For urine sample collection, the rats were placed in separate metabolic cages and were fasted; 24-hr samples of urine were collected into bottles containing 0.5 ml of saturated boric acid solution as an antiseptic. The urine samples were centrifuged at 3,000 x g for 2 min and the supernatant was obtained.
For the measurement of angiotensin I liberation from urine by renin, urine samples were freshly collected from the bladder by the following procedure: Male rats were anesthetized with sodium pentobarbital (35 mg/kg, i.p.), and the bladder was accessed through a small midline laparotomy. After the posterior urethra was occluded with a thread, urine in the bladder was removed with a syringe equipped with a 27-G needle. Subsequent urine samples were collected in the same way after 1 hr.
Blood (40 pl) obtained from the tail-tip of each animal by cutting with a razor was collected into a heparinized capillary tube. The tube was centrifuged at 1,000 x g for 20 min, and 15 ,al of plasma was obtained.
Urine collection from intact male, castrated male and female rats during growth Urine samples were collected from 10 male and 5 female rats when they were 3-week-old; 5 of the 10 male rats were then castrated. Subsequent urine samples were collected when the animals were 5-, 7-, 9 and 11-week old.
Urine collection from castrated adult male rats Six adult male rats (aged 11 weeks) were castrated, and 5 of them were subjected to sham-operation, as a control. Urine samples were collected 2 and 4 weeks after the operations.
Testosterone administration in castrated male rats Thirteen male rats were castrated when they were 3 week-old. From the age of 5 weeks, 7 of these animals received s.c. injection of 17a-methyltestosterone dis solved in propylene glycol (10 mg/kg/day) for 3 weeks, and the remaining 6 rats received vehicle only. Urine sam ples were collected when the animals were 5-, 6-, 7 and 8 week-old.
Angiotensinogen assay Angiotensinogen was measured by two different methods: direct radioimmunoassay and indirect assay. The direct radioimmunoassay was carried out with 1151_ labeled rat angiotensinogen and a rabbit antibody against rat angiotensinogen, as described previously (5). This assay permitted the detection of as little as 5 ng angioten sinogen per ml. The within-assay precision, as represent ed by the coefficient of variation of duplicates ranging throughout the standard curve, was ±3.907o, and the be tween-assay reproducibility was 7.0%. The indirect assay was carried out for urine samples collected freshly from the bladder. The amount of angiotensin I generated by a sufficient amount of partially purified rat renin was meas ured, as described previously (6) . The urine angiotensino gen assay was carried out immediately after urine was col lected, since preservation of urine at low temperature caused the formation of insoluble precipitates containing angiotensinogen (1).
Northern blot analysis of angiotensinogen mRNA A plasmid containing rat complementary DNA (cDNA) encoding angiotensinogen (7) was kindly supplied by Professor S. Nakanishi (Kyoto University School of Medicine, Kyoto), and the 1097-base pair Accl fragment of pRagl6 was prepared as the hybridization probe. The cDNA fragment was radiolabeled with [a-32P]dCTP (3000 Ci/mmol) by random priming (8) . Rat liver and kid ney total RNA, isolated by the acid guanidinium thio cyanate-phenol-chloroform method (9), was dissolved in sterile water; the concentration was then determined by absorbance readings at 260 nm. Aliquots (10 pg for liver and 20 pg for kidney) of total RNA were electrophoresed in a 1.2% agarose gel containing 20 mM 3-(N-morpho lino) propanesulfonic acid, 1 mM EDTA, 8 mM sodium acetate (pH 4.0), and 2.2 M formaldehyde and transferred onto a nylon membrane (Hybond-N+;
Amersham, Little Chalfont, UK). The filters were subjected to UV irradiation (4.5 J/cm2) and prehybridized at 651C for 30 min in a hybridization buffer (1076 bovine serum albumin, 1 mM EDTA, 7 % SDS and 5076 formamide in 0.5 M so dium phosphate, pH 7.2) (10), following which, they were hybridized in hybridization buffer at 651C with 32P-labeled cDNA for 16-18 hr and then rinsed with 1 mM EDTA and 1 °1o SDS. Autoradiography was performed with X-ray films (Fuji-RX; Fuji Photo Co., Tokyo) in the presence of an image intensifying screen (Cronex; Du Pont-New England Nuclear, Wilmington, DE, USA) at 90C for 10 hr for hepatic angiotensinogen mRNA and for 6 days for renal angiotensinogen mRNA. Findings were quantitated by computer-assisted videodensitometry using the National Institutes of Health image analysis software, IMAGE (version 1.41). The filters were reprobed with a 32P-labeled oligonucleotide (41-mer) that hybridizes with 18S ribosomal RNA (rRNA) as a control for loading. The angiotensinogen mRNA/ 18S rRNA ra tio was determined for estimating tissue angiotensinogen mRNA concentration.
Other assays
Urine protein was determined with a Bio-Rad protein assay kit, using bovine gamma-globulin as the standard. Albumin in urine was measured by an enzyme-linked immunosorbent assay, using a rabbit anti-rat albumin, a mouse anti-rat albumin and a horse radish peroxidase conjugated goat anti-mouse IgG.
Statistical analyses
Results were expressed as the mean±S.D. Statistical comparisons of urinary excretion of angiotensinogen, plasma levels of angiotensinogen and angiotensinogen mRNA were initially performed by one-way analysis of variance (ANOVA), this being applied for each of the three variables: sex difference, effect of castration and effect of testosterone. If the one-way ANOVA was sig nificant, differences were tested by Bonferroni's method. Significance was defined as P<0.05. , castrated male (diagonal ly shaded column) and intact male rats (closed column) at different ages. Twenty-four-hour samples of urine or plasma were collected from the rats (N = 5 in each group) at different ages, as indicated in the figure; and angiotensinogen in the samples was measured by direct radioimmunoassay with anti-rat angiotensinogen antibody and 125I-labeled rat angiotensinogen. ***P<0.001 vs. female or castrated male rats.
RESULTS
Urinary excretion and plasma levels of angiotensinogen in intact male, castrated male and female rats at different ages Urine samples were collected from 10 male and 5 female 3-week-old rats, and the amounts of angiotensin ogen excreted into 24-hr urine samples were measured by direct radioimmunoassay.
The displacement curve for urine samples in this assay was parallel to that for an giotensinogen purified from rat plasma, as described previously (1). There were no significant differences in an giotensinogen excretion between the 3-week-old male and female rats (Fig. 1) . Five of the 10 male rats were then cas trated at this age, and the amount of angiotensinogen in 24-hr urine was measured when the animals were 5-, 7-, 9 and 11-week-old. At 5 weeks of age, angiotensinogen excretion was higher than at 3 weeks (P <0.001) in all animals, the intact males, females, and the castrated males, but there were no significant differences between these three groups. These levels were maintained in the fe males and the castrated males until they were 11-week old, while, in contrast, male rats excreted about fourfold higher amounts of angiotensinogen after the age of 7 weeks than that observed at 5 weeks (Fig. 1) . That is, there was a sexual difference in the urinary excretion of an giotensinogen in adult rats, and this difference appeared to be androgen-dependent.
To determine whether the sexual differences in angioten sinogen excretion depended upon levels of circulating angiotensinogen, we measured plasma levels of angioten sinogen in these groups of rats during growth (Fig. 1) . As seen in the figure, there was no significant difference be tween these groups of animals in plasma levels of an giotensinogen at any age. Urinary excretion of angiotensinogen in adult male rats after castration To determine whether angiotensinogen excretion in adult male rats was androgen-dependent, we castrated 6 adult male rats (aged 11 weeks) and performed a sham operation on 5 animals as a control (Fig. 2) . The urinary excretion of angiotensinogen was significantly decreased by about 50% at 2 weeks after castration; They were fur ther reduced by about 25% after 4 weeks to levels being equal to the levels in female rats.
Effects of testosterone treatment on urinary excretion of angiotensinogen in castrated male and female rats
To confirm the involvement of androgen in the sexual differences in urine angiotensinogen, we carried out testosterone treatment in castrated male rats. Thirteen male rats were castrated at 3 weeks of age, and from 2 weeks after castration, 7 of them were injected s.c. with 17a-methyltestosterone (10 mg/kg) once a day for 3 weeks. The remaining 6 animals received vehicle only (propylene glycol, 1 ml/kg). As shown in Fig. 3 , urine an giotensinogen was significantly increased in the castrated male rats by the repeated injection of methyltestosterone for 2 or 3 weeks, but no significant change was observed in the castrated males given the vehicle only. The plasma level of angiotensinogen in the castrated males that had received methyltestosterone for 3 weeks was 45.2±4.2 pg/ml (N = 7); this was not significantly different (P > 0.1) from that in the vehicle-treated rats (45.5 ± 5.1 pg/ml, N = 6). Urine angiotensinogen was also measured in female rats (aged 9 weeks) after s.c. injection of 17a-methyl testosterone (10 mg/kg/day) once a day for 2 weeks, and a significant increase in urine angiotensinogen was ob served in the methyltestosterone-treated group (1.23 ± 0.56 pg/24-hr urine, N = 5) as compared to the vehicle treated group (0.40 ± 0.15 pg/24-hr urine, N = 6) (P < 0.05).
Urinary excretion of total protein and albumin in intact male, castrated male and female rats at different ages The kidney is a target organ for androgen, particularly in mice; androgen stimulates the induction of a number of specific gene products that are secreted into the urine (11) . As shown in Fig. 4 , the amount of total protein in 24-hr urine was significantly higher in intact adult males than in age-matched females and castrated male rats, the profiles being quite similar to that observed for urine an giotensinogen. To determine whether this sexual differ ence in urinary protein excretion was due to differences in the glomerular filtration of plasma proteins, we measured the amount of albumin in 24-hr urine. As shown in Fig. 4 , there was no significant difference in urine albumin be tween the male and female rats at 5, 7, or 11 weeks of age. Fig. 4 . Urinary excretion of total protein (A) and albumin (B) in female (open column), castrated male (diagonally shaded column) and intact male rats (closed column) at different ages. Urine samples were collected from the three groups of animals as described in the legend of Fig. 1 and the amounts of total protein and albumin were measured, as described in the text. ***P<0.001 vs. female or castrated male rats. (8 ) , female ( Y ) and castrated male (C) rats. The total RNA ex tracted from each tissue (20 Elg for kidney and 10 pg for liver) was applied to gels, and each blot was hybridized with 32P-labeled rat angiotensinogen cDNA probe (upper panel). The blots were re hybridized with a 32P-labeled oligonucleotide recognizing 18S rRNA as the internal recovery marker (lower panel). B: Quantitative analysis of renal (open column) and hepatic (closed column) angiotensinogen mRNA in intact male, female and castrated male rats. Northern blot analysis was performed on renal and hepatic angiotensinogen from 4 animals in each group, followed by den sitometric analysis. The ratio of angiotensinogen mRNA to 18S rRNA in each RNA sample was normalized relative to the mean value of the ratio in tissues from male rats; this value was arbitrarily taken to be 100%. **P<0.01 and ***P<0.001 vs. male rats.
Angiotensinogen mRNA levels in kidneys and livers of intact adult male, castrated male and female rats
The intact male, female and castrated male rats that had been used for the growth experiments shown in Fig. 1 were sacrificed at 11 weeks of age. The total RNA was ex tracted from the kidney and liver and subjected to Northern blot analysis for angiotensinogen mRNA. The renal angiotensinogen mRNA was higher in intact males than in castrated males and female rats, as shown in a rep resentative Northern blot in Fig. 5 . In contrast, hepatic angiotensinogen mRNA in males was similar to that in cas trated male or female rats. Northern blot analysis was car ried out for 4 intact males, 4 castrated males and 4 female rats; and concentrations of angiotensinogen mRNA were quantified by determining the ratio of angiotensinogen mRNA to 18S ribosomal RNA (Fig. 5) . Significantly higher levels of angiotensinogen mRNA were expressed in the kidneys of intact adult males than in castrated male or female rats, whereas there was no significant difference in the hepatic expression of angiotensinogen mRNA be tween these groups of animals. ) and hepatic (closed column) anigotensinogen mRNA in castrated male rats after treatment with 17a-methyltestosterone or vehicle. Northern blot analysis was performed on renal and hepatic angiotensinogen mRNA in methyltestosterone (N = 7) and vehicle treated (N=6) rats, followed by densitometric analysis. The ratio of angiotensinogen mRNA to l8S rRNA in each RNA sample was nor malized relative to the mean value of the ratio in tissues from vehicle-treated rats; this value was arbitrarily taken to be 100%. *P<0 .05 vs. vehicle-treated rats. Effects of testosterone treatment on angiotensinogen mRNA levels in kidneys and livers of castrated male rats Castrated male rats used in the testosterone treatment experiments were sacrificed after the 3-week period of dai ly injections of vehicle or methyltestosterone was ended, and the total RNA was extracted from the kidneys and livers. A representative blot and the quantified data for an giotensinogen mRNA in the kidneys and livers are shown in Fig. 6 . As seen in the figure, methyltestosterone treat ment for 3 weeks resulted in about twofold elevation of angiotensinogen mRNA in the kidney, whereas there was no significant change in the hepatic levels of angiotensino gen mRNA.
Measurement of angiotensin I liberation from plasma and urine of intact male rats by excess renin
The polyclonal antibodies we used for the direct radioimmunoassay of angiotensinogen recognize both in tact angiotensinogen and des-angiotensin I-angiotensin ogen (12) . The latter form is a product of angiotensinogen depleted of angiotensin I by the action of renin. To determine which form of protein was predominant in rat urine, we measured angiotensinogen concentration by an indirect assay that estimated the angiotensin I liberated from angiotensinogen by renin. Urine samples that had ac cumulated in bladder for 1 hr, as well as plasma samples, were collected from mature male rats (aged 9 weeks). Table 1 shows the concentration of angiotensinogen in these samples; values were expressed as pmol per ml. The plas ma concentration of angiotensinogen was slightly lower when measured by the indirect assay than by the direct as say, and the mean indirect/direct ratio was about 0.8, in dicating that about 80070 of the immunoreactive angioten sinogen corresponded to a form of intact angiotensinogen in plasma. Angiotensinogen in urine, on the other hand, was as low as 1/100 of that in plasma as measured by the direct assay, and the mean indirect/direct ratio of urine samples was 0.11, indicating that only 11070 of the im munoreactive angiotensinogen corresponded to the intact form. Similar results were obtained in the 24-hr urine sam ples collected from the male and female rats (aged 9 weeks) in metabolic cages, the mean indirect/direct ratio being 0.07 for males (N=5) and 0.12 for females (N=5).
DISCUSSION
The results of this study show that angiotensinogen ex cretion in urine increased during puberty in intact male rats but not in female or castrated male rats, indicating the sexual dimorphism of urine angiotensinogen. Testosterone administration to castrated male rats result ed in increases in the urinary excretion of angiotensino gen, indicating that this sexual difference was androgen dependent. However, as was indicated in this study, not only the excretion of angiotensinogen but also that of the total protein in urine increased in male rats during pu berty, suggesting that androgen regulates the excretion of a number of proteins, including angiotensinogen. As stated above, the kidney is an androgen target organ, parti cularly in mice (11) . In these animals, androgen stimu lates hypertrophy of the proximal tubule with the induc tions of a number of specific gene products such as p-gluc uronidase, ornithine decarboxylase, and kidney androgen regulated protein (11) ; these proteins are excreted in urine (13) .
Plasma angiotensinogen, which is mainly derived from the liver, did not change in either male or female rats dur ing puberty. A similar result was obtained in the testoster one treatment experiment, in which plasma levels of an giotensinogen in castrated male rats were not altered by 21-day methyltestosterone treatment. This evidence sug gests that the androgen-induced increase in urine angioten sinogen does not depend upon circulating angiotensino gen. Assuming that a major part of urine angiotensinogen in adult male rats is derived from plasma due to changes in kidney function, such as increased glomerular filtration of plasma angiotensinogen or decreased protein reabsorp tion by renal tubules, it is possible that other plasma pro teins that usually appear in urine might have a similar profile to that of urine angiotensinogen. However, the ab sence of a correlation between the urinary excretion of an giotensinogen and albumin in adult rats might deprive this hypothesis of support as accounting for the sexual differences in urine angiotensinogen.
Ellison et al. (4) demonstrated that renal angiotensino gen mRNA concentration increased in male rats but not in female rats during puberty and decreased in male adult rats after castration. They also showed that 20-day testosterone replacement caused significant increases in the renal expression of angiotensinogen mRNA in castrat ed male and in female rats. Consistent with their results, we observed that renal angiotensinogen mRNA concent ration was significantly higher in intact adult males than in age-matched females or castrated male rats, and that concentrations were increased in castrated male rats by testosterone treatment. In contrast, the hepatic expres sion of angiotensinogen mRNA in male rats was not al tered by castration or by testosterone treatment following castration. Thus, there is a good correlation between the urinary excretion of angiotensinogen and the expression of angiotensinogen mRNA in the kidney, whereas there was no correlation for the hepatic expression of anigoten sinogen mRNA. This evidence lends further support to the idea that urine angiotensinogen is derived from the kidney.
In our indirect assay of angiotensinogen, in which an giotensin I liberated by renin was estimated, we observed that only about 11 % of the immunoreactive angiotensino gen in adult male rats released angiotensin I due to the ac tion of excess renin, in contrast to the plasma, in which about 80% of the immunoreactive angiotensinogen re leased angiotensin I. In our previous study (1), we found that the angiotensinogen-like immunoreactivity present in rat urine could not be distinguished from intact plasma an giotensinogen on the displacement curve of the radioim munoassay, and that this immunoreactivity was localized at the molecular weights corresponding to those of plas ma angiotensinogen on Western blot analysis. These find ings indicate that the majority of the angiotensinogen-like immunoreactivity consists of an angiotensin I-depleted form, probably des-angiotensin I-angiotensinogen. There fore, it would appear that urine angiotensinogen may indirectly reflect the activity of the intrarenal renin-angio tensin system. Indeed, it has been demonstrated that an giotensinogen mRNA is produced primarily in the prox imal convoluted tubule (3), where angiotensin-converting enzyme, angiotensin I, angiotensin II and angiotensin receptors have all been found (2) . Thus, it is very likely that angiotensinogen is synthesized in the proximal tubule and secreted into the tubular lumen, where renin, prob ably delivered from the juxtaglomerular cells by filtration or by the interstitial fluid (14, 15) , acts on the angioten sinogen to generate angiotensin I and des-angiotensin I angiotensinogen.
The latter subsequently appears in urine, although part may be taken up and degraded by epithelial cells in the tubules.
Angiotensin II receptors are highly expressed in the proximal tubule (16) . At this site, physiological concentra tions of angiotensin II increase sodium reabsorption (17) , stimulate the Na+-H+ antiporter (18) and enhance bicar bonate reabsorption (19) . Since the generation of angio tensin II in the lumen of the proximal tubule depends upon the supply of both renin and angiotensinogen for this region, it is tempting to speculate that androgen-in duced stimulation of the renal expression of angiotensino gen leads to enhancement of local angiotensin II produc tion, which, in turn, enhances sodium reabsorption in the proximal tubule. The renal effect of androgen is of par ticular interest with regard to the sexual dimorphism of blood pressure in several forms of hypertension such as that shown by the Dahl salt-sensitive rat (20) , the spon taneously hypertensive rat (SHR) (21) and the deoxycor ticosterone acetate-NaCI hypertensive rat (22) . In these animals, hypertension develops more rapidly and becomes more severe in intact males than in age-matched females or castrated males. In fact, a recent report by Chen et al. suggests that the androgen-dependent develop ment of hypertension in SHR is related to androgen-in duced activation of the renin-angiotensin system (23) . It may be of interest to investigate the urinary excretion of angiotensinogen in hypertensive rats in relation to the development of hypertension.
In conclusion, we found an androgen-dependent sexual difference in urine angiotensinogen in the rat; and this difference was closely correlated with the renal expression of angiotensinogen mRNA, suggesting that the amount of angiotensinogen excreted into urine reflects the intra renal production of this protein.
